Richard N. Grant Jr. - 10 Mar 2025 Form 4 Insider Report for INTEST CORP (INTT)

Role
President & CEO, Director
Signature
/s/ Richard N. Grant, Jr.
Issuer symbol
INTT
Transactions as of
10 Mar 2025
Net transactions value
-$29,069
Form type
4
Filing time
12 Mar 2025, 17:37:33 UTC
Previous filing
27 Aug 2024
Next filing
19 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INTT Common Stock Sale $20,106 -2,688 -1.6% $7.48 162,241 10 Mar 2025 Direct F1, F2
transaction INTT Common Stock Sale $8,963 -1,184 -0.73% $7.57 161,057 11 Mar 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INTT Employee Stock Option (right to buy) 30,536 10 Mar 2025 Common Stock 30,536 $11.33 Direct F4
holding INTT Employee Stock Option (right to buy) 16,988 10 Mar 2025 Common Stock 16,988 $16.06 Direct F5
holding INTT Employee Stock Option (right to buy) 25,692 10 Mar 2025 Common Stock 25,692 $9.76 Direct F6
holding INTT Employee Stock Option (right to buy) 112,000 10 Mar 2025 Common Stock 112,000 $10.62 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.35 to $7.52, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $7.60, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 This option vests in four equal annual installments commencing on March 6, 2025.
F5 This option vests in four equal annual installments commencing on March 8, 2024.
F6 This option vests in four equal annual installments commencing on March 9, 2023.
F7 This option is fully vested as of the date of this report.